That has resulted in various drugs normally used in transplant treatment being applied in rheumatic disorders, for example, cyclosporin.
They do all this with no side effects.
The National Institutes of Health is also underwriting one, with results expected in about five years.
The disease causes pain, swelling and loss of movement when bone rubs against bone after the cartilage has deteriorated.
One reason is because Vioxx is designed as a once-a-day pill, while Celebra will have to be taken several times daily.
As a result, drugs could be developed that stopped the pain, but left the stomach alone.
The drugs have been touted as possibly the next wonder pills because of their promise to be easier on patients' stomachs than existing medications.
As a result, analysts say it is likely doctors will use Vioxx and Celebrex interchangeably.
When Wray suggested that they also take a look at the placebo effect, Moseley was taken aback.
``If the pill is bigger, you'll measure a bigger effect''.
It was suggestive enough to set Moseley and Wray on an expanded version of the same research design _ this time with 180 patients _ for which they expect to have the results next October.
For centuries, Western medicine consisted of almost nothing but the placebo effect.
For years, scientists have tried to come up with a plausible explanation for the placebo effect, and there are by now several contenders.
These can cause ulcers, stomach bleeding and other side effects, especially in long-term users.
